Proton-pump inhibitors and birth defects -- some reassurances, but more needed warns epidemiologist

November 24, 2010

Despite the reassurances of Pasternak and Hviid in their study, "Use of Proton-Pump Inhibitors (PPI) in Early Pregnancy and the Risk of Birth Defects," featured in the Nov. 24 issue of the New England Journal of Medicine, an epidemiologist from Boston University School of Medicine (BUSM) believes that further studies are needed.

The original study found that on the basis of data from more than 840,000 live births in Denmark, there was no evidence to suggest that the use of the most common PPIs (omeprazole, lansoprazole, and esomeprazole) anytime during pregnancy increased the risk of birth defects overall, and in the case of omeprazole, the PPI used most commonly during pregnancy, they found no evidence of a risk among selected subgroups of major birth defects. "These findings, together with earlier reports that were based on smaller numbers of pregnant women exposed to PPIs, are important in providing some reassurance about the safety of these drugs when they are taken during pregnancy," said editorial author Allen A. Mitchell, MD, director of BUSM's Slone Epidemiology Center. "However, as the authors acknowledge, these data provide only a broad — and incomplete —overview," he added.

According to Mitchell, drugs that cause birth defects, called teratogens, tend to increase the risks of specific birth defects, not birth defects overall. Secondly, although medications in the same class (e.g., PPIs) share pharmacologic effects, they may have very different effects on the fetus. Of particular importance, Mitchell points out that despite the large size of this study population, "it was still too small to consider the risks of specific birth defects in relation to specific PPIs, which is what we need to know." One finding of possible concern is that women who took PPIs in the weeks just before pregnancy—but not during pregnancy—seemed to have an increased risk of birth defects, and this observation needs to be understood; the one PPI that did not show any increased risk during these weeks before pregnancy was omeprazole.

Lastly, despite the richness of the data sources used for the Danish study, Mitchell notes that they lack information on important variables that could themselves account for possible associations between medications and birth defects, including the reasons for the use of PPIs. They also lack information on exposures to over-the-counter medications; among this latter group, for example, it is critical to know whether women were taking folic-acid around the time of conception, since folic acid has been repeatedly shown to reduce the risk of a number of birth defects.

Mitchell points out that the report by Pasternak and Hviid represents the best available data on the possible risk of birth defects associated with the use of PPIs during pregnancy, and it supports two conclusions. First, the PPIs most commonly represented in the study do not appear to carry major risks of when they are taken during the first trimester or later in . Second, the modestly increased risk during the period before conception that was observed with PPIs as a group was not seen with omeprazole.

Further studies using a case–control design are needed to consider specific defects in relation to individual PPIs, and future analyses must also include information on critical additional variables, such as use of folic acid supplements around the time of conception. "Until such studies are available, the current findings, although reassuring, must be considered far from definitive," stressed Mitchell.

Related Stories

Recommended for you

Health warnings on cigarettes could deter young people

December 11, 2017
Young people are less likely to try cigarettes with the printed health warning 'Smoking kills' on each stick than standard cigarettes, according to a new study by Cancer Research UK published in Nicotine & Tobacco Research.

Multiple health implications of women's early marriage go beyond early childbearing

December 11, 2017
A new study of four South Asian countries reveals complex associations between early marriage and women's education, health and nutrition that go beyond the impacts of early childbearing. These health implications—which ...

Over 50s with fewer than 20 teeth at higher risk of musculoskeletal frailty

December 11, 2017
New research by scientists at King's College London has found that tooth loss may contribute to musculoskeletal frailty in the over 50s, with those with fewer than 20 teeth being at greatest risk.

Poor sleep could lead to heavier drinking in young adults, study finds

December 8, 2017
A shortened night of sleep may increase young adults' risk of heavier drinking, according to a new Yale study that assessed reciprocal variations in sleep and drinking over time in young adults.

Researchers say nutritional labeling for sodium doesn't work

December 8, 2017
Potato chips, frozen pizza, a fast food hamburger-these foods are popular in the American diet and saturated with sodium. Though eating too much can lead to high blood pressure and heart disease, 90 percent of Americans eat ...

Observation care may save more than thought

December 8, 2017
In the world of health care spending policy, it usually works that as Medicare goes so goes private insurance on matters of managing the cost and quality of care.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.